Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model

Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023

Place navigation impaired in rats with hippocampal lesions

Morris, R. G. M., Garrud, P., Rawlins, J. N. P., & O'Keefe, J. (1982) · Nature · doi:10.1038/297681a0 · Cited by 6,340

Global prevalence of dementia: a Delphi consensus study

Ferri, C. P., Prince, M. J., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K. S., Hasegawa, K., Hendrie, H. C., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,336

2016 Alzheimer's disease facts and figures

Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744

Microglia: Active sensor and versatile effector cells in the normal and pathologic brain

Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676

Biodegradable polymeric nanoparticles as drug delivery devices

Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549

Biodegradation and biocompatibility of PLA and PLGA microspheres

Anderson, J. M., & Shive, M. S. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00048-3 · Cited by 2,617

Alzheimer's disease

Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336

Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases

Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609

Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology

Zielińska, A., Carreiró, F., Oliveira, A. M., Neves, A., Pires, B., Venkatesh, D. N., Durazzo, A., Lucarini, M., Eder, P., Silva, A. M., et al. (2020) · Molecules · doi:10.3390/molecules25163731 · Cited by 1,560

Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles

Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645

Green Tea Derivative Driven Smart Hydrogels with Desired Functions for Chronic Diabetic Wound Treatment

Zhao, X., Pei, D., Yang, Y., Xu, K., Yu, J. X., Zhang, Y., Zhang, Q., He, G., Zhang, Y., Li, A., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202009442 · Cited by 510

Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier

Zha, S., Liu, H., Li, H., Li, H., Wong, K.-L., & All, A. H. (2024) · ACS Nano · doi:10.1021/acsnano.3c10674 · Cited by 378

Applications of Phyto-Nanotechnology for the Treatment of Neurodegenerative Disorders

Bhattacharya, T., Soares, G. A. B. E., Chopra, H., Rahman, M. M., Hasan, Z., Swain, S. S., & Cavalu, S. D. (2022) · Materials · doi:10.3390/ma15030804 · Cited by 267

Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation

Ashok, A., Andrabi, S. S., Mansoor, S., Kuang, Y., Kwon, B. K., & Labhasetwar, V. D. (2022) · Antioxidants · doi:10.3390/antiox11020408 · Cited by 270

Nanoparticle Delivery Systems in the Treatment of Diabetes Complications

Souto, E. B., Souto, S. B., Campos, J. R. S., Severino, P. B., Pashirova, T. N., Zakharova, L. Y., Silva, A. M., Durazzo, A., Lucarini, M., Izzo, A. A., et al. (2019) · Molecules · doi:10.3390/molecules24234209 · Cited by 254

Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancement

Aggarwal, V., Tuli, H. S., Tania, M., Srivastava, S., Ritzer, E. E., Pandey, A., Aggarwal, D., Barwal, T. S., Jain, A., Kaur, G., et al. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.05.011 · Cited by 232

Nanodelivery of Natural Antioxidants: An Anti-aging Perspective

Vaiserman, A. M., Koliada, A. K., Zayachkivska, A., & Lushchak, O. V. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00447 · Cited by 215

Multifaceted role of phyto-derived polyphenols in nanodrug delivery systems

Chen, Z., Farag, M. A., Zhong, Z., Zhang, C., Yang, Y. P., Wang, S., & Wang, Y. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113870 · Cited by 176

Nanotechnology-based drug delivery for central nervous system disorders

Nguyen, T. T., Nguyen, T. T. D., Vo, T. K., An, T. N. M., Nguyen, M. K., Toi, V. V., & Vo, G. V. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112117 · Cited by 182

Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects

Pritam, P., Deka, R., Bhardwaj, A., Srivastava, R., Kumar, D., Jha, A. K., Jha, N. K., Villa, C., & Jha, S. K. (2022) · Biology · doi:10.3390/biology11020212 · Cited by 188

Oxidative stress, the blood–brain barrier and neurodegenerative diseases: The critical beneficial role of dietary antioxidants

Feng, J., Zheng, Y., Guo, M., Arés, I., Martínez, M., López-Torres, B., Martínez‐Larrañaga, M., Wang, X., Anadón, A., & Martínez, M. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.07.010 · Cited by 187

Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics

Mukherjee, S., Madamsetty, V. S., Bhattacharya, D., Roy Chowdhury, S., Paul, M. K., & Mukherjee, A. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202003054 · Cited by 152

Nanomaterials as Nanofertilizers and Nanopesticides: An Overview

Okey‐Onyesolu, C. F., Hassanisaadi, M., Bilal, M., Barani, M., Rahdar, A., Iqbal, J., & Kyzas, G. Z. (2021) · ChemistrySelect · doi:10.1002/slct.202102379 · Cited by 154

Current Understanding of Polyphenols to Enhance Bioavailability for Better Therapies

Aatif, M. (2023) · Biomedicines · doi:10.3390/biomedicines11072078 · Cited by 166

Nanopharmaceutics: part I-Clinical trials legislation and good manufacturing practices (GMP) of nanotherapeutics in the EU

Souto, E. B., Silva, G. F., Dias-Ferreira, J., Zielinska, A., Ventura, F., Durazzo, A., Lucarini, M., Novellino, E., & Santini, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020146 · Cited by 144

Current Advances in The Development of Novel Polymeric Nanoparticles for The Treatment of Neurodegenerative Diseases

Cano, A., Sánchez-López, E., Ettcheto, M., López-Machado, A., Espina, M., Souto, E. B., Galindo, R., Camins, A., García, M. L., & Turowski, P. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0443 · Cited by 144

Nano-Phytomedicine: Harnessing Plant-Derived Phytochemicals in Nanocarriers for Targeted Human Health Applications

Parvin, N., Aslam, M., Joo, S., & Mandal, T. K. (2025) · Molecules · doi:10.3390/molecules30153177 · Cited by 165

Flavonoids as Promising Neuroprotectants and Their Therapeutic Potential against Alzheimer’s Disease

Minocha, T., Birla, H., Obaid, A. A., Rai, V., Pradeep, S., Shivamallu, C., Moustafa, M., Al-Shehri, M., Al‐Emam, A., Tikhonova, M. A., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6038996 · Cited by 159

Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease

Uddin, M. S., Kabir, M. T., Niaz, K., Jeandet, P., Clément, C., Mathew, B., Rauf, A., Rengasamy, K. R. R., Sobarzo‐Sánchez, E., Ashraf, G. M., et al. (2020) · Molecules · doi:10.3390/molecules25061267 · Cited by 135

Dual glucose/ros-sensitive injectable adhesive self-healing hydrogel with photothermal antibacterial activity and modulation of macrophage polarization for infected diabetic wound healing

Zhou, X., Ning, X., Chen, Y., Chang, H., Lu, D., Pei, D., Geng, Z., Zeng, Z., Guo, C., Huang, J., et al. (2023) · ACS Materials Letters · doi:10.1021/acsmaterialslett.3c00925 · Cited by 127

Recent Advances in the Treatment of Alzheimer’s Disease Using Nanoparticle-Based Drug Delivery Systems

Poudel, P., & Park, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040835 · Cited by 124

Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges

Cano, A., Turowski, P., Ettcheto, M., Duskey, J. T., Tosi, G., Sánchez-López, E., García, M. L., Camins, A., Souto, E. B., Ruiz, A., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00864-x · Cited by 122

In Vitro and In Vivo Comparison of Curcumin-Encapsulated Chitosan-Coated Poly(lactic- co -glycolic acid) Nanoparticles and Curcumin/Hydroxypropyl-β-Cyclodextrin Inclusion Complexes Administered Intranasally as Therapeutic Strategies for Alzheimer’s Disease

Zhang, L., Yang, S., Wong, L. R., Xie, H., & Ho, P. C. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00675 · Cited by 122

Lipid Peroxidation and Antioxidant Supplementation in Neurodegenerative Diseases: A Review of Human Studies

Petrović, S., Arsić, A., Ristić-Medić, D., Cvetković, Z., & Vučić, V. (2020) · Antioxidants · doi:10.3390/antiox9111128 · Cited by 123

Wound healing strategies based on nanoparticles incorporated in hydrogel wound patches

Dam, P., Celik, M., Ustun, M., Saha, S., Saha, C., Kacar, E. A., Kugu, S., Karagülle, E. N., Taşoğlu, S., Büyükserin, F., et al. (2023) · RSC Advances · doi:10.1039/d3ra03477a · Cited by 119

ROS-Induced mtDNA Release: The Emerging Messenger for Communication between Neurons and Innate Immune Cells during Neurodegenerative Disorder Progression

Zhao, Y., Liu, B., Xu, L., Yu, S., Fu, J., Wang, J., Yan, X., & Su, J. (2021) · Antioxidants · doi:10.3390/antiox10121917 · Cited by 121

Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases

Gonçalves, P. B., Sodero, A. C. R., & Cordeiro, Y. (2021) · Biomolecules · doi:10.3390/biom11050767 · Cited by 115

Epigallocatechin gallate/L-ascorbic acid–loaded poly-γ-glutamate microneedles with antioxidant, anti-inflammatory, and immunomodulatory effects for the treatment of atopic dermatitis

Chiu, Y.-H., Wu, Y., Hung, J.-I., & Chen, M. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.05.032 · Cited by 111

Green Tea Polyphenol Epigallocatechin-Gallate in Amyloid Aggregation and Neurodegenerative Diseases

Fernandes, L., Cardim-Pires, T. R., Foguel, D., & Palhano, F. L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.718188 · Cited by 114

An Insight to Brain Targeting Utilizing Polymeric Nanoparticles: Effective Treatment Modalities for Neurological Disorders and Brain Tumor

Annu, Sartaj, A., Qamar, Z., Md, S., Alhakamy, N. A., Baboota, S., & Ali, J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.788128 · Cited by 110

Bioavailability of Epigallocatechin Gallate Administered with Different Nutritional Strategies in Healthy Volunteers

Andreu-Férnández, V., Almeida-Toledano, L., Pizarro, N., Navarro‐Tapia, E., Gómez‐Roig, M. D., de la Torre, R., & García‐Algar, Ó. (2020) · Antioxidants · doi:10.3390/antiox9050440 · Cited by 112

Recent Advances in Nanomaterials for Dermal and Transdermal Applications

Zoabi, A., Touítou, E., & Margulis, K. (2021) · Colloids and Interfaces · doi:10.3390/colloids5010018 · Cited by 106

Enhancement of the permeability and activities of epigallocatechin gallate by quaternary ammonium chitosan/fucoidan nanoparticles

Huang, T., Ho, Y., Tsai, T.-N., Tseng, C., Lin, C., & Mi, F. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116312 · Cited by 99

Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery

Maher, R., Moreno-Borrallo, A., Jindal, D., Mai, B. T., Ruiz‐Hernández, E., & Harkin, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030746 · Cited by 104

Transferrin-Conjugated Docetaxel–PLGA Nanoparticles for Tumor Targeting: Influence on MCF-7 Cell Cycle

Jose, S., Cinu, T. A., Sebastian, R., Shoja, M. H., Aleykutty, N., Durazzo, A., Lucarini, M., Santini, A., & Souto, E. B. (2019) · Polymers · doi:10.3390/polym11111905 · Cited by 91

Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery

Ege, D. (2021) · Materials · doi:10.3390/ma14123332 · Cited by 97

Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform

Pinto, M., Silva, V., Barreiro, S., Silva, R. V. D. S., Remião, F., Borges, F., & Fernandes, C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101658 · Cited by 97

Nanopharmaceutics: Part II—Production Scales and Clinically Compliant Production Methods

Souto, E. B., Silva, G. F., Dias-Ferreira, J., Zielińska, A., Ventura, F. V., Durazzo, A., Lucarini, M., Novellino, E., & Santini, A. (2020) · Nanomaterials · doi:10.3390/nano10030455 · Cited by 87

Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies

Alam, M., Gulzar, M., Akhtar, S., Rashid, S., Zulfareen, Tanuja, Shamsi, A., & Hassan, M. I. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00240-9 · Cited by 109

Epigallocatechin-3-Gallate Provides Protection Against Alzheimer’s Disease-Induced Learning and Memory Impairments in Rats

Nan, S., Wang, P., Zhang, Y., & Fan, J. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s289473 · Cited by 83

Development of Lactoferrin-Loaded Liposomes for the Management of Dry Eye Disease and Ocular Inflammation

López-Machado, A., Díaz‐Garrido, N., Cano, A. C., Espina, M., Badı́a, J., Baldomà, L., Calpena, A. C., Souto, E. B., García, M. L., & Sánchez‐López, E. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101698 · Cited by 78

PLGA-PEG Nanoparticles Facilitate In Vivo Anti-Alzheimer’s Effects of Fucoxanthin, a Marine Carotenoid Derived from Edible Brown Algae

Yang, M., Jin, L., Wu, Z., Xie, Y., Zhang, P., Wang, Q., Yan, S., Chen, B., Liang, H., Naman, C. B., et al. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c00569 · Cited by 86

Flavonoids as an Intervention for Alzheimer’s Disease: Progress and Hurdles Towards Defining a Mechanism of Action

Hole, K. L., & Williams, R. J. (2020) · Brain Plasticity · doi:10.3233/bpl-200098 · Cited by 81

Therapeutic Potential of Phytoconstituents in Management of Alzheimer’s Disease

Singh, S. P., Nand, S., Maurya, A., Mishra, G., Awasthi, R., Shakya, A., Chellappan, D. K., Dua, K., Vamanu, E., Chaudhary, S. K., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5578574 · Cited by 77

The Pharmacological Activity of Epigallocatechin-3-Gallate (EGCG) on Alzheimer's Disease Animal Model: A Systematic Review

Zhang, S., Zhu, Q., Chen, J.-Y., OuYang, D., & Lu, J.-H. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153316 · Cited by 74

Nanotechnology for delivery of natural therapeutic substances: a review

Saka, R., & Chella, N. (2021) · Environmental Chemistry Letters · doi:10.1007/s10311-020-01103-9 · Cited by 74

Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice

Ettcheto, M., Cano, A., Manzine, P. R., Busquets, O., Verdaguer, E., Castro-Torres, R. D., García, M. L., Beas-Zarate, C., Olloquequi, J., Auladell, C., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-019-01849-6 · Cited by 73

Enzyme-mediated one-pot synthesis of hydrogel with the polyphenol cross-linker for skin regeneration

Kim, B. S., Kim, S., Kim, K., An, Y., So, K., Kim, B.-G., & Hwang, N. S.-Y. (2020) · Materials Today Bio · doi:10.1016/j.mtbio.2020.100079 · Cited by 70

Radioprotective Effect of Flavonoids on Ionizing Radiation-Induced Brain Damage

Wang, Q., Xie, C., Xi, S.-J., Qian, F., Peng, X., Huang, J., & Tang, F.-R. (2020) · Molecules · doi:10.3390/molecules25235719 · Cited by 73

Dual-drugs delivery in solid lipid nanoparticles for the treatment of Candida albicans mycosis

Carbone, C., Fuochi, V., Zielińska, A., Musumeci, T., Souto, E. B., Bonaccorso, A., Puglia, C., Petronio, G. P., & Furneri, P. M. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110705 · Cited by 68

Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases

Riccardi, C., Napolitano, F., Montesarchio, D., Sampaolo, S., & Melone, M. A. B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111897 · Cited by 70

Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective

Nayab, D. E., Din, F. U., Ali, H., Kausar, W. A., Urooj, S., Zafar, M., Khan, I., Shabbir, K., & Khan, G. M. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02250-1 · Cited by 68

Platelet-Tumor Cell Hybrid Membrane-Camouflaged Nanoparticles for Enhancing Therapy Efficacy in Glioma

Wu, L., Li, Q., Deng, J., Shen, J., Xu, W., Yang, W., Chen, B., Du, Y., Zhang, W., Ge, F., et al. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s333279 · Cited by 64

Neurodegenerative diseases and catechins: (−)-epigallocatechin-3-gallate is a modulator of chronic neuroinflammation and oxidative stress

Li, S., Wang, Z., Liu, G., & Chen, M. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1425839 · Cited by 64

Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation

Puricelli, C., Gigliotti, C. L., Stoppa, I., Sacchetti, S., Pantham, D., Scomparin, A., Rolla, R., Pizzimenti, S., Dianzani, U., Boggio, E. M., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061772 · Cited by 62

Cancer Chemoprevention by Flavonoids, Dietary Polyphenols and Terpenoids

(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac111.85028537 · Cited by 60

Ferulic Acid-NLC with Lavandula Essential Oil: A Possible Strategy for Wound-Healing?

Carbone, C., Caddeo, C., Grimaudo, M. A., Manno, D. E., Serra, A., & Musumeci, T. (2020) · Nanomaterials · doi:10.3390/nano10050898 · Cited by 61

Neuroinflammation in pathogenesis of Alzheimer’s disease: Phytochemicals as potential therapeutics

Vaiserman, A. M., Koliada, A. K., & Lushchak, O. V. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111259 · Cited by 57

Development and optimization of Riluzole-loaded biodegradable nanoparticles incorporated in a mucoadhesive in situ gel for the posterior eye segment

Esteruelas, G., Halbaut, L., García-Torra, V., Espina, M., Cano, A. C., Ettcheto, M., Camins, A., Souto, E. B., García, M. L., & Sánchez‐López, E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121379 · Cited by 56

Phytochemicals: A Promising Alternative for the Prevention of Alzheimer’s Disease

Koul, B., Farooq, U., Yadav, D., & Song, M. (2023) · Life · doi:10.3390/life13040999 · Cited by 60

Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders

Неганова, М. Е., Aleksandrova, Y. R., Sukocheva, O. A., & Klochkov, S. G. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.06.011 · Cited by 56

Duo of (–)-epigallocatechin-3-gallate and doxorubicin loaded by polydopamine coating ZIF-8 in the regulation of autophagy for chemo-photothermal synergistic therapy

Chen, X., Tong, R., Liu, B., Liu, H., Feng, X., Ding, S., Lei, Q., Tang, G., Wu, J., & Fang, W. (2019) · Biomaterials Science · doi:10.1039/c9bm01614g · Cited by 53

Innovative Therapies and Nanomedicine Applications for the Treatment of Alzheimer’s Disease: A State-of-the-Art (2017–2020)

Binda, A., Murano, C., & Rivolta, I. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s231480 · Cited by 56

Nanotechnology for Neurodegenerative Diseases: Recent Progress in Brain-Targeted Delivery, Stimuli-Responsive Platforms, and Organelle-Specific Therapeutics

Gao, L., Wang, J., & Bi, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s549893 · Cited by 52

Polyphenols and Their Nanoformulations: Protective Effects against Human Diseases

Anand, S., Ramachandregowda, S., Ansari, M. A., Alzohairy, M. A., Alomary, M. N., Almalik, A. I., Ahmad, W., Tripathi, T., & Elderdery, A. Y. (2022) · Life · doi:10.3390/life12101639 · Cited by 56

A Tumor-Specific Ferric-Coordinated Epigallocatechin-3-gallate cascade nanoreactor for glioblastoma therapy

Mu, M., Chen, H., Fan, R., Wang, Y., Tang, X., Lan, M., Zhao, N., Zou, B., Tong, A., Xu, J., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.07.010 · Cited by 51

Encapsulation of β-carotene in high internal phase Pickering emulsions stabilized by soy protein isolate – epigallocatechin-3-gallate covalent composite microgel particles

Geng, M., Li, L., Feng, X., Xu, J., Huang, Y., Teng, F., & Li, Y. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.119511 · Cited by 46

Neuroprotective effect of phytoconstituents via nanotechnology for treatment of Alzheimer diseases

Paramanick, D., Singh, V. D., & Singh, V. K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.058 · Cited by 47

Application of green tea extracts epigallocatechin‐3‐gallate in dental materials: Recent progress and perspectives

Liao, S., Tang, Y., Chu, C., Lu, W., Baligen, B., Man, Y., & Qu, Y. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36991 · Cited by 46

Flavonoid-Based Nanomedicines in Alzheimer’s Disease Therapeutics: Promises Made, a Long Way To Go

Prasanna, P., & Upadhyay, A. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00224 · Cited by 48

Potential of Nano-Antioxidants and Nanomedicine for Recovery from Neurological Disorders Linked to Long COVID Syndrome

Akanchise, T., & Angelova, A. (2023) · Antioxidants · doi:10.3390/antiox12020393 · Cited by 47

Challenges and opportunities for improving the druggability of natural product: Why need drug delivery system?

Tang, P., Shen, T., Wang, H., Zhang, R., Zhang, X., Li, X., & Xiao, W. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114955 · Cited by 46

EGCG/HP-β-CD inclusion complexes integrated into PCL/Chitosan oligosaccharide nanofiber membranes developed by ELS for fruit packaging

Hu, G., Luo, F., Han, J., Li, J., Zhou, C., Yang, C., Wang, Z., Yang, W., & Hu, Y. (2023) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2023.108992 · Cited by 44

Potential of flavonoids as anti-Alzheimer’s agents: bench to bedside

Kaur, R., Sood, A., Lang, D. K., Bhatia, S., Al‐Harrasi, A., Aleya, L., & Behl, T. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-18165-z · Cited by 45

Mechanistic insights into the potential role of dietary polyphenols and their nanoformulation in the management of Alzheimer’s disease

Albadrani, H. M., Chauhan, P., Ashique, S., Babu, M. A., Iqbal, D., Almutary, A. G., Abomughaid, M. M., Kamal, M., Paiva‐Santos, A. C., Alsaweed, M., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116376 · Cited by 46

Unraveling Neurological Drug Delivery: Polymeric Nanocarriers for Enhanced Blood-Brain Barrier Penetration

Inamdar, A., Gurupadayya, B., Halagali, P., Tippavajhala, V. K., Khan, F. R., Pathak, R., & Sharma, H. (2024) · Current Drug Targets · doi:10.2174/0113894501339455241101065040 · Cited by 45

mRNA delivery enabled by metal–organic nanoparticles

Gu, Y., Chen, J., Wang, Z., Liu, C., Wang, T., Kim, C., Ďuríková, H., Fernandes, S., Johnson, D. N., Rose, R. D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53969-w · Cited by 44

Metformin restores cognitive dysfunction and histopathological deficits in an animal model of sporadic Alzheimer's disease

Rabieipoor, S., Zare, M., Ettcheto, M., Camins, A., & Javan, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17873 · Cited by 41

Nanodelivery of phytobioactive compounds for treating aging-associated disorders

Lushchak, O. V., Strilbytska, O. M., Koliada, A. K., Zayachkivska, A., Burdyliuk, N., Yurkevych, I. S., Storey, K. B., & Vaiserman, A. M. (2020) · GeroScience · doi:10.1007/s11357-019-00116-9 · Cited by 40

Nanotechnological approaches for targeting amyloid-β aggregation with potential for neurodegenerative disease therapy and diagnosis

Shukla, R., Singh, A., Handa, M., Flora, S. J. S., & Kesharwani, P. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.04.011 · Cited by 40

Electrically controlled drug release of donepezil and BiFeO3 magnetic nanoparticle-loaded PVA microbubbles/nanoparticles for the treatment of Alzheimer's disease

Cesur, S., Çam, M. E., Sayın, F. S., & Gündüz, O. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102977 · Cited by 42

Nanoparticles in Endodontics Disinfection: State of the Art

Roig, X., Souto, E. B., Elmsmari, F., García, M. L., Espina, M., Durán‐Sindreu, F., Sánchez‐López, E., & Sánchez, J. A. G. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071519 · Cited by 41

Epigallocatechin-3-Gallate PEGylated Poly(Lactic-Co-Glycolic) Acid Nanoparticles Mitigate Striatal Pathology and Motor Deficits in 3-Nitropropionic Acid Intoxicated Mice

Cano, A. C., Ettcheto, M., Espina, M., Auladell, C., Folch, J., Kühne, B. A., Barenys, M., Sánchez‐López, E., Souto, E. B., García, M. L., et al. (2021) · Nanomedicine · doi:10.2217/nnm-2020-0239 · Cited by 40

Development of topical eye-drops of lactoferrin-loaded biodegradable nanoparticles for the treatment of anterior segment inflammatory processes

López-Machado, A., Díaz‐Garrido, N., Cano, A. C., Espina, M., Badı́a, J., Baldomà, L., Calpena, A. C., Biancardi, M., Souto, E. B., García, M. L., et al. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121188 · Cited by 39

Natural and biocompatible dressing unit based on tea carbon dots modified core-shell electrospun fiber for diabetic wound disinfection and healing

Dong, Z., Yin, J., Zhou, X., Li, S., Fu, Z., Liu, P., Shen, L., & Shi, W. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113325 · Cited by 38

Modulating Inflammation-Mediated Diseases via Natural Phenolic Compounds Loaded in Nanocarrier Systems

Rakotondrabe, T. F., Fan, M., Muema, F. W., & Guo, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020699 · Cited by 41

EGCG Alleviates Oxidative Stress and Inhibits Aflatoxin B1 Biosynthesis via MAPK Signaling Pathway

Xu, D., Peng, S., Guo, R., Yao, L., Mo, H., Li, H., Song, H., & Hu, L. (2021) · Toxins · doi:10.3390/toxins13100693 · Cited by 39

Chemical and biological evaluation of cross-linked halloysite-curcumin derivatives

Massaro, M., Poma, P., Colletti, C. G., Barattucci, A., Bonaccorsi, P. M., Lazzara, G., Nicotra, G., Parisi, F., Salerno, T. M. G., Spinella, C., et al. (2019) · Applied Clay Science · doi:10.1016/j.clay.2019.105400 · Cited by 36

Management of Brain Cancer and Neurodegenerative Disorders with Polymer-Based Nanoparticles as a Biocompatible Platform

Alahri, M. B., Ibrahim, A. J., Barani, M., Arkaban, H., Shadman, S. M., Salarpour, S., Zarrintaj, P., Jaberi, J., & Jalil, A. T. (2023) · Molecules · doi:10.3390/molecules28020841 · Cited by 37

Nanomedicines for Alzheimer's disease: Therapies based on pathological mechanisms

Cheng, G., Xie, A., Yan, Z., Zhu, X., Song, Y., & Chen, T. (2023) · Brain‐X · doi:10.1002/brx2.27 · Cited by 35

Natural polyphenols in preclinical models of epilepsy

Dhir, A. (2020) · Phytotherapy Research · doi:10.1002/ptr.6617 · Cited by 35

Phytochemical Compounds and Nanoparticles as Phytochemical Delivery Systems for Alzheimer’s Disease Management

Bakrim, S., Aboulaghras, S., Menyiy, N. E., Omari, N. E., Assaggaf, H. M., Lee, L., Montesano, D., Gallo, M., Zengin, G., Al-Dhaheri, Y., et al. (2022) · Molecules · doi:10.3390/molecules27249043 · Cited by 34

Dually Active Apigenin-Loaded Nanostructured Lipid Carriers for Cancer Treatment

Bonilla-Vidal, L., Świtalska, M., Espina, M., Wietrzyk, J., García, M. L., Souto, E. B., Gliszczyńska, A., & Sánchez‐López, E. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s429565 · Cited by 35

Food‐borne polyphenols: A biocompatible anchor recuperating iron homeostasis

Li, Y., Feng, X., Zheng, X., Zhu, J., & Gu, Q. (2023) · Food Frontiers · doi:10.1002/fft2.244 · Cited by 32

Nanotechnology-Based Approaches for the Management of Diabetes Mellitus: An Innovative Solution to Long-Lasting Challenges in Antidiabetic Drug Delivery

Sarkhel, S., Shuvo, S. M., Ansari, M. A., Mondal, S., Kapat, P., Ghosh, A., Sarkar, T., Biswas, R., Atanase, L. I., & Cărăuleanu, A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121572 · Cited by 32

Great green tea ingredient? A narrative literature review on epigallocatechin gallate and its biophysical properties for topical use in dermatology

Frasheri, L., Schielein, M. C., Tizek, L., Mikschl, P., Biedermann, T., & Zink, A. (2020) · Phytotherapy Research · doi:10.1002/ptr.6670 · Cited by 32

Approaches to overcome bioavailability inconsistencies of epigallocatechin gallate, a powerful anti-oxidant in green tea

Furniturewalla, A., & Barve, K. H. (2022) · Food Chemistry Advances · doi:10.1016/j.focha.2022.100037 · Cited by 32

Effectiveness of epigallocatechin gallate nanoparticles on the in-vivo treatment of Alzheimer’s disease in a rat/mouse model: a systematic review

Khalifa, M. K. A., Abdel-Sattar, S. A., Amin, O. M., Kohaf, N. A., Zaky, H. S., El-Fattah, M. A. A., Mohammed, K. H. A., Badawi, N. M., Mansoor, I., & Eassa, H. A. (2023) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-023-00494-8 · Cited by 8

[Constructing Brain Aβ-Targeting Nanoparticles Loaded with EGCG for Treating Alzheimer's Disease in Mice].

Yang, P., Guo, Q., Xu, S., Sheng, D., & Zhang, Q. (2021) · PubMed Central · doi:10.12182/20210760206 · Cited by 1

Brain‐targeted co‐delivery of β‐amyloid converting enzyme 1 shRNA and epigallocatechin‐3‐gallate by multifunctional nanocarriers for Alzheimer's disease treatment

Lv, L., Yang, F., Li, H., & Yuan, J. (2020) · IUBMB Life · doi:10.1002/iub.2330 · Cited by 39

EGCG Nanoparticles Attenuate Aluminum Chloride Induced Neurobehavioral Deficits, Beta Amyloid and Tau Pathology in a Rat Model of Alzheimer’s Disease

Singh, N. A., Bhardwaj, V., Ravi, C., Ramesh, N., Mandal, A. K. A., & Khan, Z. A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00244 · Cited by 198

Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease

Smith, A., Giunta, B., Bickford, P. C., Fountain, M., Tan, J., & Shytle, R. D. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.01.012 · Cited by 280